Search research articles
Contact Us
Filters
Showing results (1-10 of 308) with videos related to
Page
of 31
Sort By:
British Journal of Clinical Pharmacology
|
August 19, 2011
When to publish measures of disproportionality derived from spontaneous reporting databases?
Anthonius de Boer
Journal of the American College of Cardiology
|
January 17, 2015
Increased mortality by digoxin in patients with atrial fibrillation?
Anthonius de Boer
Current Pharmaceutical Design
|
March 9, 2010
Pharmacogenetics of oral anticoagulant therapy
Tom Schalekamp, Anthonius de Boer
Drugs
|
November 18, 2010
Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus
Taina K Mattila, Anthonius de Boer
British Journal of Clinical Pharmacology
|
September 23, 2015
Digoxin and mortality: lessons for observational studies
Anthonius de Boer, Adam F Cohen
Nederlands Tijdschrift Voor Geneeskunde
|
January 8, 2011
[Separate pharmaceutical budgets: skating on thin ice]
Antoine C G Egberts, Anthonius de Boer
British Journal of Clinical Pharmacology
|
April 29, 2018
Commentary on 'Gender differences in clinical registration trials; is there a real problem?' by Labots et al
Christine Gispen-de Wied, Anthonius de Boer
Bone
|
August 9, 2011
Acid suppressants and hip fracture: duplicate publication bias?
Marloes Bazelier, Anthonius de Boer, Frank de Vries
Journal of Clinical Epidemiology
|
April 24, 2020
The design can limit PRECIS-2 retrospective assessment of the clinical trial explanatory/pragmatic features
Rafael Dal-Ré, Anthonius de Boer, Stefan K James
British Journal of Clinical Pharmacology
|
September 17, 2020
Demographics in the 2020s-Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life
Sven Stegemann, Diana van Riet-Nales, Anthonius de Boer
Page
of 31
Search research articles
Search
Showing results (1-10 of 308) with videos related to
Sort By:
Page
of 31
British Journal of Clinical Pharmacology
|
August 19, 2011
When to publish measures of disproportionality derived from spontaneous reporting databases?
Anthonius de Boer
Journal of the American College of Cardiology
|
January 17, 2015
Increased mortality by digoxin in patients with atrial fibrillation?
Anthonius de Boer
Current Pharmaceutical Design
|
March 9, 2010
Pharmacogenetics of oral anticoagulant therapy
Tom Schalekamp, Anthonius de Boer
Drugs
|
November 18, 2010
Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus
Taina K Mattila, Anthonius de Boer
British Journal of Clinical Pharmacology
|
September 23, 2015
Digoxin and mortality: lessons for observational studies
Anthonius de Boer, Adam F Cohen
Nederlands Tijdschrift Voor Geneeskunde
|
January 8, 2011
[Separate pharmaceutical budgets: skating on thin ice]
Antoine C G Egberts, Anthonius de Boer
British Journal of Clinical Pharmacology
|
April 29, 2018
Commentary on 'Gender differences in clinical registration trials; is there a real problem?' by Labots et al
Christine Gispen-de Wied, Anthonius de Boer
Bone
|
August 9, 2011
Acid suppressants and hip fracture: duplicate publication bias?
Marloes Bazelier, Anthonius de Boer, Frank de Vries
Journal of Clinical Epidemiology
|
April 24, 2020
The design can limit PRECIS-2 retrospective assessment of the clinical trial explanatory/pragmatic features
Rafael Dal-Ré, Anthonius de Boer, Stefan K James
British Journal of Clinical Pharmacology
|
September 17, 2020
Demographics in the 2020s-Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life
Sven Stegemann, Diana van Riet-Nales, Anthonius de Boer
Page
of 31